Literature DB >> 9370940

Trefoil proteins: their role in normal and malignant cells.

F E May1, B R Westley.   

Abstract

The three human trefoil proteins pS2, human intestinal trefoil factor (hITF), and human spasmolytic polypeptide (hSP) are expressed principally in the mucosa of the gastrointestinal tract. They are also expressed in a variety of other normal tissues and tumours. This review discusses the pattern of expression of trefoil proteins in cancer, current views on the biological functions of trefoil proteins, and the way in which the expression of trefoil proteins may influence the behaviour of cancer cells.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9370940     DOI： 10.1002/(SICI)1096-9896(199709)183:1<4::AID-PATH1099>3.0.CO;2-5

Source DB:  PubMed          Journal:  J Pathol        ISSN： 0022-3417            Impact factor:   7.996


  31 in total

1.  Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice.

Authors:  J I Semple; J L Newton; B R Westley; F E May
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.

Authors:  J L Newton; A Allen; B R Westley; F E May
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

3.  Altered expression of TFF-1 and CES-2 in Barrett's Esophagus and associated adenocarcinomas.

Authors:  Charles A Fox; Lisa M Sapinoso; Hong Zhang; Wanghai Zhang; Howard L McLeod; Gina R Petroni; Tarun Mullick; Christopher A Moskaluk; Henry F Frierson; Garret M Hampton; Steven M Powell
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

Review 4.  Effect of age-related changes in gastric physiology on tolerability of medications for older people.

Authors:  Julia L Newton
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor.

Authors:  Somchai Chutipongtanate; Yasushi Nakagawa; Suchai Sritippayawan; Jeeraporn Pittayamateekul; Paisal Parichatikanond; Bruce R Westley; Felicity E B May; Prida Malasit; Visith Thongboonkerd
Journal:  J Clin Invest       Date:  2005-11-23       Impact factor: 14.808

Review 6.  Modulation of epithelial cell adhesion in gastrointestinal homeostasis.

Authors:  J A Efstathiou; M Pignatelli
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

7.  Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer.

Authors:  Mark J Hoenerhoff; Arun R Pandiri; Stephanie A Lahousse; Hu-Hua Hong; Tai-Vu Ton; Tiwanda Masinde; Scott S Auerbach; Kevin Gerrish; Pierre R Bushel; Keith R Shockley; Shyamal D Peddada; Robert C Sills
Journal:  Toxicol Pathol       Date:  2011-05-13       Impact factor: 1.902

8.  Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis.

Authors:  Liduan Zheng; Mixia Weng; Jun He; Xiuping Yang; Guosong Jiang; Qiangsong Tong
Journal:  Virchows Arch       Date:  2009-12-05       Impact factor: 4.064

Review 9.  Aspects of the biology of regeneration and repair in the human gastrointestinal tract.

Authors:  N A Wright
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-06-29       Impact factor: 6.237

Review 10.  Improving the gastrointestinal tolerability of aspirin in older people.

Authors:  Julia L Newton
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.